Anlotinib plus platinum-etoposide as a first-line treatment for extensive-stage small cell lung cancer: A single-arm trial.
Bo Peng DengChengping HuCen ChenLiming CaoQihua GuJian AnLing QinMin LiBaimei HeJuan JiangHuaping YangPublished in: Cancer medicine (2022)
Anlotinib combined with platinum-etoposide provided an effective and safe therapy for patients with ES-SCLC.